IDYA Earnings & Financial Statements
IDEAYA Biosciences, Inc.
$33.86
-$0.40(-1.17%)
43
Overall
60
Value
20
Tech
50
Quality
Market Cap
$3.27B
Volume
1.06M
52W Range
$26.20 - $42.68
Target Price
$51.50
IDYA earnings and financial statements: IDEAYA Biosciences, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
IDYA Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $218.71M | $7.00M | $23.39M | $50.93M | $27.94M |
| Operating income | -$159.31M | -$326.98M | -$134.43M | -$62.50M | -$50.27M |
| EBITDA | -$109.11M | -$270.64M | -$108.95M | -$55.14M | -$47.24M |
| Net income | -$113.70M | -$274.48M | -$112.96M | -$58.66M | -$49.76M |
| EPS (diluted) | $-1.28 | $-3.36 | $-1.96 | $-1.42 | $-1.41 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $1.11B | $1.12B | $649.32M | $387.97M | $381.35M |
| Total liabilities | $86.39M | $64.94M | $28.23M | $38.51M | $79.83M |
| Shareholders’ equity | $1.02B | $1.06B | $621.09M | $349.45M | $301.51M |
| Cash and equivalents | $112.83M | $84.38M | $157.02M | $68.63M | $92.05M |
| Long-term debt | $27.57M | $18.87M | $1.13M | $1.61M | $3.48M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$71.10M | -$247.58M | -$115.22M | -$87.17M | -$55.78M |
| Capital expenditure | -$2.37M | -$3.86M | -$2.37M | -$3.44M | -$2.64M |
| Free cash flow | -$73.47M | -$251.44M | -$117.59M | -$90.62M | -$58.42M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IDYA | $33.86 | -1.2% | 1.06M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get IDEAYA Biosciences, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW